Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics

被引:14
|
作者
Misawa, N
Matsumoto, A
Tanaka, E
Rokuhara, A
Yoshizawa, K
Umemura, T
Maki, N
Kimura, T
Kiyosawa, K
机构
[1] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 3908621, Japan
[2] Adv Life Sci Inst Inc, Wako, Saitama, Japan
[3] Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan
关键词
HBV DNA; seroconversion; HBV core-related antigen; precore mutation; core promoter mutation;
D O I
10.1002/jmv.20505
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The characteristic differences between patients with and without loss of hepatitis B virus (HBV) DNA after achieving hepatitis B e antigen seroconversion were analyzed by comparing changes in HBV DNA and HBV core-related antigen levels during a period from 3 years before to 3 years after the seroconversion. Of the 24 seroconverters, 6 (inactive replication group) showed continuous loss of HBV DNA in serum after the seroconversion and the remaining 18 did not lose HBV DNA (active replication group). The HBV DNA level was similar between the two groups, while the HBV core-related antigen level was significantly lower in the active replication group than in the inactive replication group before the seroconversion. The levels of both HBV DNA and HBV core-related antigen decreased remarkably around the time of seroconversion in the inactive replication group, while these levels did not change or decreased slightly in the active replication group. After the seroconversion, the HBV DNA level was significantly higher in the active replication group than in the inactive replication group, while the HBV core-related antigen level was similarly low between the two groups. Because the serum level of HBV core-related antigen mainly reflects that of HBe antigen, the low level of HBV core-related antigen seen after seroconversion in both groups might have contributed to the occurrence of seroconversion. The precore and core promoter mutations which cause diminished excretion of hepatitis B e antigen were significantly more frequent in the active replication group than in the inactive replication group. It was therefore considered that the seroconversion was caused mainly by a decrease in viral replication in the inactive replication group, and mainly by a decrease in HBe antigen production in the active replication group.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [11] GENETIC-HETEROGENEITY IN THE PRECORE REGION OF HEPATITIS-B VIRUS IN HEPATITIS-B E-ANTIGEN-NEGATIVE CHRONIC HEPATITIS-B PATIENTS - SPONTANEOUS SEROCONVERSION AND INTERFERON-INDUCED SEROCONVERSION
    KARASAWA, T
    AIZAWA, Y
    ZENIYA, M
    KURAMOTO, A
    SHIRASAWA, T
    TODA, G
    JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (04) : 373 - 380
  • [12] Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e AntigenNegative Chronic Hepatitis B Patients
    Nirmala, Viva Finhar Insani
    Aryati, Aryati
    Susianti, Hani
    Mustika, Syifa
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (04) : 378 - 382
  • [13] Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy
    Su, Chien-Wei
    Wu, Chun-Ying
    Hung, Hung-Hsu
    Wu, Chu-Hui
    Sheen, I-Jane
    Wu, Jaw-Ching
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (12) : 1849 - 1858
  • [14] Incidence and Determinants of Spontaneous Seroclearance of Hepatitis B e Antigen and DNA in Patients With Chronic Hepatitis B
    Yang, Hwai-I
    Hung, Hsiu-Lian
    Lee, Mei-Hsuan
    Liu, Jessica
    Jen, Chin-Lan
    Su, Jun
    Wang, Li-Yu
    Lu, Sheng-Nan
    You, San-Lin
    Iloeje, Uchenna H.
    Chen, Chien-Jen
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (05) : 527 - 534
  • [15] Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection
    Kumar, Gollapudi Tarun
    Kazim, Syed Naqui
    Kumar, Manoj
    Hissar, Syed
    Chauhan, Ranjit
    Basir, Seemi Farhat
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (04) : 588 - 598
  • [16] High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
    Lee, Eung Chang
    Kim, Seong Hoon
    Lee, Seung Duk
    Park, Hyeongmin
    Lee, Soon-Ae
    Park, Sang-Jae
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (14) : 3803 - 3812
  • [17] Prevalence of Dual-Positivity for Both Hepatitis B e Antigen and Hepatitis B e Antibody Among Hospitalized Patients with Chronic Hepatitis B Virus Infection
    Liu, Yuanyuan
    He, Songmei
    Yin, Sichun
    Zhong, Qingyang
    Zhong, Jianbo
    Zhang, Xiaoyong
    Fan, Rong
    Hou, Jinlin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 5759 - 5770
  • [18] The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen
    Nirei, K
    Kaneko, M
    Moriyama, M
    Arakawa, Y
    INTERVIROLOGY, 2000, 43 (02) : 95 - 101
  • [19] The relationship between core promoter mutation of hepatitis B virus, viral load and hepatitis B e antigen status in chronic hepatitis B patients
    Sayed, Sohair K.
    Kobeisy, Mohammad A.
    CELLULAR IMMUNOLOGY, 2012, 276 (1-2) : 35 - 41
  • [20] Controversies in Treating Chronic Hepatitis B virus The Role of Hepatitis B Virus DNA and Surface Antigen Titer
    Huang, Daniel Q.
    Kew, Guan Sen
    Lim, Seng Gee
    CLINICS IN LIVER DISEASE, 2021, 25 (04) : 763 - 784